Clinical trial Recruiting at 1 site Interventional Ages 18 to 51 Women only

Home ultrasound in telemedicine care for gestational diabetes (GDM)

Official title: Effect of Home Ultrasound in Routine High-Risk Care of Patients With Gestational Diabetes Mellitus

Run by Wolfson Medical Center · NCT07158970 · Data updated 2026-11-12

This study tests whether using a home ultrasound device at home, guided by a physician, improves satisfaction and outcomes for pregnant people with GDM compared to standard care.

More Gestational Diabetes Mellitus trials

Quick facts

Study typeInterventional
Ages18 Years to 51 Years
SexWomen only
Enrollment90 (estimated)
SponsorWolfson Medical Center
Government
Locations1 site (H̱olon, Central District)
StatusRecruiting
StartedMarch 1, 2026
Main results expectedAugust 31, 2027
Study endsNovember 1, 2027
Registry record updatedJuly 2, 2026
Trial IDNCT07158970 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are Hebrew-speaking women with singleton pregnancies and diagnosed GDM who have compatible cellphones and can participate in telemedicine.

Probably not a fit

Patients without access to compatible devices or those with exclusion criteria (e.g., pregestational diabetes, fetal anomalies, multifetal pregnancy, late GDM diagnosis) may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-center randomized trial compares standard high-risk care for gestational diabetes with a care model that adds physician-guided home ultrasound during telemedicine visits. Participants will alternate in-person and telemedicine visits, using the Pulsenmore device under real-time supervision to assess fetal status. Primary outcome is patient satisfaction at term measured by the DTSQ, with secondary outcomes including glycemic control, maternal and neonatal outcomes, healthcare utilization, visit duration, and costs. The study will enroll 90 women with singleton pregnancies and GDM at Edith Wolfson Medical Center in Israel over one year.

Why it matters

Potential benefit: If successful, the approach could improve patient satisfaction and potentially optimize monitoring while reducing in-clinic visits.

How similar studies have gone: Prior telemedicine approaches have improved access and satisfaction, but this study novelly adds home ultrasound guidance to remote care.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Singleton pregnancy
* GDM diagnosed by OGTT or glucose monitoring
* Hebrew speaking
* Compatible cellphone

Exclusion Criteria:

* Pregestational diabetes
* Fetal anomalies/genetic abnormalities
* Multifetal pregnancy
* Late GDM diagnosis (after 34 weeks)

Where it's running

  • Edith Wolfson Medical Center
    H̱olon, Central District, Israel
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.